Effects of verteporfin therapy on contrast sensitivity: Results from the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation - TAP Report No. 4

Retina

Volumn 22, Issue 5, 2002, Pages 536-544

  Rubin, Gary S ^a   Bressler, Neil M ^a,a   Arnold, Jennifer ^a   Kilmartin, Dara ^a   Olson, John ^a   Neville, Sean ^a   Robinson, Karon ^a   Laird, Allison ^a   Richmond, Claire ^a   Farrow, Alison ^a   McKay, Sandra ^a   McKechnie, Rhona ^a   Evans, Gary ^a   Schachat, Andrew P ^a   Bressler, Susan B ^a   Nesbitt, Pat ^a   Porter, Tracey ^a   Hawse, Patricia ^a   Hartnett, Mike ^a   Eager, Ann ^a   Belt, Judy ^a   Cain, Dennis ^a   Emmert, David ^a   George, Terry ^a   Herring, Mark ^a   McDonald, Jaquelyn ^a   Monés, Jordi ^a   Corcóstegui, Borja ^a   Gilbert, Montse ^a   Duran, Nuria ^a   Sisquella, Maite ^a   Nolla, Ana ^a   Margalef, Alfons ^a   Miller, Joan W ^a   Gragoudas, Evangelos S ^a   Lane, Anne Marie ^a   Emmanuel, Nicholas ^a   Holbrook, Amy ^a   Evans, Claudia ^a   Lord, Ursula Szajta ^a   Walsh, Davis K ^a   Callahan, Charlene D ^a   DuBois, Jennifer L ^a   Moy, Jennifer ^a   Kenney, Alice George ^a   Milde, Inge ^a   Platz, Eric S ^a   Lewis, Hilel ^a   Kaiser, Peter K ^a   Holody, Laura J ^a   Lesak, Erica ^a   Lichterman, Susan ^a   Siegel, Helene ^a   Fattori, Anthony ^a   Ambrose, Ginny ^a   Fecko, Tami ^a   Ross, Deborah ^a   Burke, Stephanie ^a   Conway, Joyce ^a   Singerman, Lawrence ^a   Zegarra, Hernando ^a   Novak, Michael ^a   Bartel, Michelle ^a   Tilocco DuBois, Kimberly ^a   Ilc, Mary ^a   Schura, Stephanie ^a   Joyce, Sheri ^a   Tanner, Vivian ^a   Rowe, Pam ^a   Smith Brewer, Sheila ^a   Kukula, Donna ^a   Greanoff, Greg ^a   Daley, Geraldine ^a   DuBois, John ^a   Lehnhardt, David ^a   Fish, Gary Edd ^a   Jost, Bradley F ^a   Anand, Rajiv ^a   Callanan, David ^a   Arceneaux, Sally ^a   Arnwine, Jean ^a   Ellenich, Penny ^a   King, John ^a   Aguado, Hank ^a   Collins, Rubye ^a   Anderson, Teresa ^a   Nork, Cynthia ^a   Duignan, Karen ^a   Boleman, Bob ^a   Poumaras, Constantin J ^a   Donati, Guy ^a   Kapetanios, Anastasios D ^a   Cavalière, Katty ^a   Guney Wagner, S ^a   Gerber, N ^a   Sickenberg, Michel ^a   Sickenberg, Valérie ^a   Gans, Alice ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Contrast sensitivity; Verteporfin; Visual function

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUORESCEIN;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0036796124     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200210000-00002     Document Type: Article

References (21)

1. Leat SJ, Woodhouse JM. Reading performance with low vision aids: relationship with contrast sensitivity. Ophthalmic Physiol Opt 1993;13:9-16.
2. Marron JA, Bailey IL. Visual factors and orientation-mobility performance. Am J Optom Physiol Opt 1982;59:413-426.
3. McClure ME, Hart PM, Jackson AJ, et al. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 2000;84:244-250.
4. Owsley C, Sekuler R, Boldt C. Aging and low-contrast vision: face perception. Invest Ophthalmol Vis Sci 1981;21:362-365.
5. Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of 'real-world' targets. Br J Ophthalmol 1987;71:791-796.
6. Rubin GS, Roche KB, Prasada-Rao P, Fried LP. Visual impairment and disability in older adults. Optom Vis Sci 1994;71:750-760.
7. Rubin GS, Bandeen-Roche K, Huang GH, et al. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci 2001;42:64-72.
8. Hakkinen L. Vision in the elderly and its use in the social environment. Scand J Soc Med Suppl 1984;35:5-60.
9. Rubin GS. Prevalence of vision disabilities and their relationship to visual impairment. In: Massof R, Lidoff L, eds. Low vision rehabilitation: policy, service delivery, policy and funding. New York: AFB Press, 2001.
10. Evans DW, Ginsburg AP. Contrast sensitivity predicts age-related differences in highway-sign discriminability. Hum Factors 1985;27:637-642.
11. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-1241.
12. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231.
13. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1. Arch Ophthalmol 1999;117:1329-1345.
14. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol 2001;119:198-207.
15. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vision Sci 1988;2:187-199.
16. Kuyk T, Elliott JL. Visual factors and mobility in persons with age-related macular degeneration. J Rehabil Res Dev 1999;36:303-312.
17. Lennerstrand G, Ahlstrom CO. Contrast sensitivity in macular degeneration and the relation to subjective visual impairment. Acta Ophthalmol (Copenh) 1989;67:225-233.
18. Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci 1997;38:557-568.
19. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999;76:141-158.
20. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials - TAP Report No. 5. Arch Ophthalmol 2002 (in press).
21. Rosenfeld PJ, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Visual outcomes in patients with minimally classic choroidal neovascularization (CNV): rationale for the Visudyne In Minimally classic CNV (VIM) Trial [abstract]. Invest Ophthalmol Vis Sci 2001:42:S512.